{"id":"https://openalex.org/W7155493003","doi":"https://doi.org/10.1136/jitc-2025-014677","title":"Rapid response: Context-dependent immunomodulatory effects of JAK inhibition in the management of severe immune-related adverse events","display_name":"Rapid response: Context-dependent immunomodulatory effects of JAK inhibition in the management of severe immune-related adverse events","alternate_titles":[],"publication_year":2026,"publication_date":"2026-04-01","ids":{"openalex":"https://openalex.org/W7155493003","doi":"https://doi.org/10.1136/jitc-2025-014677","pmid":"https://pubmed.ncbi.nlm.nih.gov/42031428","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13110670"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2025-014677","doi":"https://doi.org/10.1136/jitc-2025-014677","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-014677","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7155493003"],"child_works_count":0,"type":"editorial","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1136/jitc-2025-014677","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051374671","display_name":"Lingrong Tang","orcid":"https://orcid.org/0000-0001-6446-7345","observed_orcids":["https://orcid.org/0000-0001-6446-7345"]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lingrong Tang","raw_affiliation_strings":["Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China"],"raw_orcid":"https://orcid.org/0000-0001-6446-7345","affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China","institution_ids":["https://openalex.org/I4210140515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008841592","display_name":"Wenbin Mo","orcid":"https://orcid.org/0000-0002-4030-256X","observed_orcids":["https://orcid.org/0000-0002-4030-256X"]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wenbin Mo","raw_affiliation_strings":["Department of Hematology, The First Hospital of China Medical University, Shenyang, Liaoning, China"],"raw_orcid":"https://orcid.org/0000-0002-4030-256X","affiliations":[{"raw_affiliation_string":"Department of Hematology, The First Hospital of China Medical University, Shenyang, Liaoning, China","institution_ids":["https://openalex.org/I4210140515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100341069","display_name":"Nan Li","orcid":"https://orcid.org/0000-0002-6855-4910","observed_orcids":["https://orcid.org/0000-0002-6855-4910"]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Nan Li","raw_affiliation_strings":["Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China"],"raw_orcid":"https://orcid.org/0000-0002-6855-4910","affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China","institution_ids":["https://openalex.org/I4210140515"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043650344","display_name":"Guangwei Tian","orcid":"https://orcid.org/0000-0002-3470-4925","observed_orcids":["https://orcid.org/0000-0002-3470-4925"]},"institutions":[{"id":"https://openalex.org/I4210140515","display_name":"First Hospital of China Medical University","ror":"https://ror.org/04wjghj95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210140515"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Guangwei Tian","raw_affiliation_strings":["Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China"],"raw_orcid":"https://orcid.org/0000-0002-3470-4925","affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China","institution_ids":["https://openalex.org/I4210140515"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5043650344"],"corresponding_institution_ids":["https://openalex.org/I4210140515"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"4","first_page":"e014677","last_page":"e014677"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.7760000228881836},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.984000027179718},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7620000243186951},{"id":"https://openalex.org/keywords/myocarditis","display_name":"myocarditis","score":0.7770000100135803},{"id":"https://openalex.org/keywords/inflammatory-arthritis","display_name":"inflammatory arthritis","score":0.9950000047683716},{"id":"https://openalex.org/keywords/stat-signaling","display_name":"STAT signaling","score":0.75},{"id":"https://openalex.org/keywords/thromboembolic-risk","display_name":"thromboembolic risk","score":0.8899999856948853},{"id":"https://openalex.org/keywords/opportunistic-infections","display_name":"opportunistic infections","score":0.7260000109672546},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.6729999780654907}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.873199999332428},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.8234999775886536},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7766000032424927},{"id":"https://openalex.org/C2778886723","wikidata":"https://www.wikidata.org/wiki/Q3530324","display_name":"Tofacitinib","level":3,"score":0.61080002784729},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.49779999256134033},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.46869999170303345},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.44940000772476196},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4426000118255615},{"id":"https://openalex.org/C32465701","wikidata":"https://www.wikidata.org/wiki/Q14914514","display_name":"Janus kinase 2","level":3,"score":0.44029998779296875},{"id":"https://openalex.org/C171958077","wikidata":"https://www.wikidata.org/wiki/Q419333","display_name":"STAT protein","level":4,"score":0.42669999599456787},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.388700008392334},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.38679999113082886},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3718999922275543},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36809998750686646},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3472999930381775},{"id":"https://openalex.org/C157333092","wikidata":"https://www.wikidata.org/wiki/Q902835","display_name":"JAK-STAT signaling pathway","level":4,"score":0.3449999988079071},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.32760000228881836},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.32269999384880066},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3160000145435333},{"id":"https://openalex.org/C2780875844","wikidata":"https://www.wikidata.org/wiki/Q186235","display_name":"Myocarditis","level":2,"score":0.2903999984264374},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26660001277923584},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.2502000033855438}],"mesh":[{"descriptor_ui":"D000075242","descriptor_name":"Janus Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000075242","descriptor_name":"Janus Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D056747","descriptor_name":"Immunomodulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1136/jitc-2025-014677","doi":"https://doi.org/10.1136/jitc-2025-014677","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-014677","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13110670","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13110670/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13110670/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Immunother Cancer","raw_type":"Text"},{"id":"pmid:42031428","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42031428","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for immunotherapy of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:c36205627d114810a4d227966da33c5a","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c36205627d114810a4d227966da33c5a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 14, Iss 4 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2025-014677","doi":"https://doi.org/10.1136/jitc-2025-014677","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-014677","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7155493003.pdf","grobid_xml":"https://content.openalex.org/works/W7155493003.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W4210529991","https://openalex.org/W4399848783","https://openalex.org/W4399848851","https://openalex.org/W4413946481","https://openalex.org/W4416827100"],"related_works":["https://openalex.org/W7165204526","https://openalex.org/W4416827100","https://openalex.org/W4410810680","https://openalex.org/W7167463847","https://openalex.org/W4411804041","https://openalex.org/W4411395397","https://openalex.org/W4379648471","https://openalex.org/W4404029393","https://openalex.org/W4407315162","https://openalex.org/W4407315631"],"abstract_inverted_index":{"Recent":[0],"studies":[1,154],"have":[2],"indicated":[3],"that":[4],"Janus":[5],"kinase":[6],"inhibitors":[7,47],"(JAKi)":[8],"exert":[9],"context-dependent":[10],"immunomodulatory":[11],"effects":[12,97],"in":[13,61,87,115,170],"cancer":[14],"immunotherapy.":[15],"In":[16],"this":[17],"rapid":[18],"response,":[19],"we":[20],"comment":[21],"on":[22],"the":[23,75,110,141,145,148,165],"prospective":[24,153],"cohort":[25,146],"study":[26,50],"by":[27,99],"Habib":[28],"et":[29],"al":[30],",":[31],"which":[32],"evaluates":[33],"JAKi":[34,114],"for":[35],"steroid-refractory":[36],"or":[37],"life-threatening":[38],"immune-related":[39],"adverse":[40],"events":[41],"(irAEs)":[42],"associated":[43],"with":[44,58,155],"immune":[45,103],"checkpoint":[46],"(ICIs).":[48],"The":[49],"demonstrated":[51],"a":[52],"clinical":[53,92,142],"remission":[54],"rate":[55],"of":[56,78,83,113,123,144,167],"70.8%,":[57],"notable":[59],"activity":[60],"myocarditis":[62],"and":[63,81,102,135,147,157,174],"inflammatory":[64],"arthritis.":[65],"Although":[66],"JAK":[67,168],"inhibition":[68,169],"has":[69],"historically":[70],"raised":[71],"concern":[72],"due":[73],"to":[74,162],"central":[76],"role":[77,166],"JAK-signal":[79],"transducer":[80],"activator":[82],"transcription":[84],"(STAT)":[85],"signaling":[86],"interferon-mediated":[88],"antitumor":[89,175],"immunity,":[90],"emerging":[91],"data":[93],"indicate":[94],"more":[95],"nuanced":[96],"influenced":[98],"timing,":[100],"dosing,":[101],"context.":[104],"This":[105],"framework":[106],"may":[107],"help":[108],"explain":[109],"observed":[111],"efficacy":[112],"controlling":[116],"severe":[117],"irAEs":[118],"without":[119],"an":[120],"apparent":[121],"excess":[122],"opportunistic":[124],"infections.":[125],"We":[126],"also":[127],"emphasize":[128],"unresolved":[129],"safety":[130],"considerations,":[131],"including":[132],"thromboembolic":[133],"risk":[134],"disease":[136],"progression":[137],"during":[138],"follow-up.":[139],"Given":[140],"heterogeneity":[143],"limited":[149],"oncologic":[150],"detail,":[151],"further":[152],"stratified":[156],"time-to-event":[158],"analyses":[159],"are":[160],"needed":[161],"better":[163],"define":[164],"balancing":[171],"irAE":[172],"control":[173],"immunity.":[176]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7155493003","counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2026-04-25T00:00:00"}
